Related references
Note: Only part of the references are listed.Evaluation of 29 indicators for the prognosis of advanced non-small cell lung cancer with cytokine-induced killer cell therapy combined with chemotherapy
Hejin Jia et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
Autologous cytokine-induced killer cell therapy in lung cancer patients: A retrospective study
Jinying Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Modification of chemokine receptor expression to enhance levels of trafficking receptors on autologous cytokine-induced killer cells derived from patients with colorectal cancer
Dan Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
Clinical research of genetically modified dendritic cells in combination with cytokine-induced killer cell treatment in advanced renal cancer
Danhong Wang et al.
BMC CANCER (2014)
Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer
Moon Jae Chung et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Clinical Activity of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Post-Mastectomy Triple-Negative Breast Cancer
Ke Pan et al.
CLINICAL CANCER RESEARCH (2014)
An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells
Clara E. Jaekel et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2014)
Combination of radiofrequency ablation and sequential cellular immunotherapy improves progression-free survival for patients with hepatocellular carcinoma
Jiuwei Cui et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies
Frederic Carsten Schmeel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Maintenance Therapy With Autologous Cytokine-induced Killer Cells in Patients With Advanced Epithelial Ovarian Cancer After First-line Treatment
Jun Liu et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy with Cytokine-Induced Killer Cells Improves Survival in Gastric and Colorectal Cancer Patients
Daiqing Gao et al.
PLOS ONE (2014)
A prospective study of the efficacy of a combination of autologous dendritic cells, cytokine-induced killer cells, and chemotherapy in advanced non-small cell lung cancer patients
Runbo Zhong et al.
TUMOR BIOLOGY (2014)
Gypenoside attenuates hepatic ischemia/reperfusion injury in mice via anti-oxidative and anti-apoptotic bioactivities
Jie Zhao et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2014)
Clinical Studies Applying Cytokine-Induced Killer Cells for the Treatment of Gastrointestinal Tumors
Clara E. Jaekel et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Adoptive T-Cell Therapy for Cancer: Boutique Therapy or Treatment Modality?
Cassian Yee
CLINICAL CANCER RESEARCH (2013)
Human dendritic cell subsets in vaccination
Karolina Palucka et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Cytokine-induced killer cells promote antitumor immunity
Jingting Jiang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Autologous cytokine-induced killer cell immunotherapy in lung cancer: a phase II clinical study
Runmei Li et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Randomized Study of Autologous Cytokine-Induced Killer Cell Immunotherapy in Metastatic Renal Carcinoma
Liang Liu et al.
CLINICAL CANCER RESEARCH (2012)
Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy
Chang-Chuan Pan et al.
Chinese Journal of Cancer (2012)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity
Alice Pievani et al.
BLOOD (2011)
Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell
Yeh C. Linn et al.
IMMUNOLOGY (2009)
In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity
Ryosei Nishimura et al.
BLOOD (2008)
Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers
Dario Sangiolo et al.
INTERNATIONAL IMMUNOLOGY (2008)
Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas
De-Sheng Weng et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma
Jung Han Kim et al.
CLINICAL IMMUNOLOGY (2007)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts
YC Linn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Regulation of cutaneous malignancy by γδ T cells
M Girardi et al.
SCIENCE (2001)
Share Paper
